FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| "QuVa Pharma, Inc.(080064259)" | Amiodarone Hydrochloride | 5.4 g/3000 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(080064259)" | Amiodarone Hydrochloride | 5.4 g/3000 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(080064259)" | Lidocaine Hydrochloride; Epinephrine | 5 mg/3000 mL; 10 ug/3000 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(080064259)" | Midazolam Hydrochloride | 3 g/3 L | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(080064259)" | Midazolam Hydrochloride | 100 g/2 L | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(080064259)" | Midazolam Hydrochloride | 3 g/3 L | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(080064259)" | Morphine Sulfate | 250 mg/500 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(080064259)" | Morphine Sulfate | 1500 mg/1500 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(080064259)" | Morphine Sulfate | 3 g/3 L | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(080064259)" | Morphine Sulfate | 3 g/3 L | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "RC Outsourcing, LLC(079935629)" | Povidone-Iodine | 50 mg/1 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "RC Outsourcing, LLC(079935629)" | Bevacizumab | 25 mg/1 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "RC Outsourcing, LLC(079935629)" | Bevacizumab | 25 mg/1 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "RC Outsourcing, LLC(079935629)" | Cefuroxime | 10 mg/1 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "RC Outsourcing, LLC(079935629)" | Lidocaine Hydrochloride | 20 mg/1 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "RC Outsourcing, LLC(079935629)" | Lidocaine Hydrochloride; Benzocaine; Tetracaine Hydrochloride | 60 mg/1 g; 200 mg/1 g; 40 mg/1 g | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "RC Outsourcing, LLC(079935629)" | Lidocaine Hydrochloride; Benzocaine; Tetracaine Hydrochloride | 60 mg/1 g; 200 mg/1 g; 40 mg/1 g | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "RC Outsourcing, LLC(079935629)" | Lidocaine Hydrochloride; Tetracaine Hydrochloride | 230 mg/1 g; 70 mg/1 g | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "RC Outsourcing, LLC(079935629)" | Lidocaine Hydrochloride; Tetracaine Hydrochloride | 230 mg/1 g; 70 mg/1 g | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Neostigmine Methylsulfate | 1 mg/1 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Phenylephrine Hydrochloride | .08 mg/1 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Phenylephrine Hydrochloride | .1 mg/1 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Phenylephrine Hydrochloride | .1 mg/1 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Phenylephrine Hydrochloride | .04 mg/1 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Rocuronium Bromide | 10 mg/1 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Rocuronium Bromide | 10 mg/1 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Succinylcholine Chloride | 20 mg/1 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Succinylcholine Chloride | 20 mg/1 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Succinylcholine Chloride | 20 mg/1 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Ephedrine Sulfate | 10 mg/1 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Ephedrine Sulfate | 5 mg/1 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Ephedrine Sulfate | 5 mg/1 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Epinephrine | .032 mg/1 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Epinephrine | .02 mg/1 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Epinephrine | .016 mg/1 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate | .02 mg/1 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate | .025 mg/1 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate | .05 mg/1 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate | .02 mg/1 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate | .05 mg/1 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate | .01 mg/1 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate | .01 mg/1 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate | .01 mg/1 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate; Ropivacaine Hydrochloride | .002 mg/1 mL; 2 mg/1 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Glycopyrrolate | .2 mg/1 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Hydromorphone Hydrochloride | .2 mg/1 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Hydromorphone Hydrochloride | 1 mg/1 mL | 2023-1 | source_no_ndc | 2026-11-08 |